ALT Altimmune, Inc. - Common Stock
$3,02
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$3–$6
12% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$17
+471% upside
P/E (TTM)
-3.0
ROE
-45.6%
Nettogewinnmarge
-214861.0%
ALT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.02
Marktkapitalisierung
$334M
P/E (TTM)
-3.0
EPS (TTM)
$-1.00
Umsatz (TTM)
$41.0K
Dividendenrendite
—
ROE
-45.6%
Verschuldungsgrad
0.2
52W-Spanne
$3 – $6
ALT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$41.0K
2016-12-31
→
2025-12-31
EPS
$-1.00
2016-12-31
→
2025-12-31
Freier Cashflow
$-68M
2016-12-31
→
2025-12-31
Margen
-214861.0%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ALT
Peer-Median
P/E (TTM)
-3.0
19.6
P/S (TTM) (K/V (TTM))
8153.9
24.9
P/B (K/B)
1.5
3.1
EV / EBITDA
-1.0
—
Price / FCF (Kurs / FCF)
-4.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ALT
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-230461.0%
—
Net Profit Margin (Nettogewinnmarge)
-214861.0%
-298.0%
ROA
-42.0%
-56.6%
ROE
-45.6%
-70.8%
ROIC
-36.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ALT
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.2
—
Current Ratio (Liquiditätsgrad)
18.5
5.2
Quick Ratio
18.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ALT
Peer-Median
Revenue YoY (Umsatz YoY)
105.0%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-83.5%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
-65.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ALT
Peer-Median
ALT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 4 26,7%
- Kauf 9 60,0%
- Halten 2 13,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-19
Median
$18.00
← Unter allen Zielen
$3.02
Tief
$11.00
Hoch
$28.00
Median-Ziel
$18.00
+497,0%
Mittelwert-Ziel
$17.22
+471,2%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.05%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.12 | $-0.14 | 0.02% |
| 31. März 2026 | $-0.18 | $-0.25 | 0.07% |
| 31. Dezember 2025 | $-0.27 | $-0.25 | -0.02% |
| 30. September 2025 | $-0.21 | $-0.28 | 0.07% |
| 30. Juni 2025 | $-0.27 | $-0.33 | 0.06% |
| 31. März 2025 | $-0.26 | $-0.37 | 0.11% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| EIKN | — | — | — | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| R&D Expense | $66M | $82M | $66M | $71M | $75M | $50M | $18M | $18M | $18M | $7M | $5M | $9M | |
| SG&A Expense | $28M | $21M | $18M | $17M | $15M | $13M | $9M | $10M | $8M | $7M | $6M | $11M | |
| Operating Expenses | $95M | $103M | $96M | $88M | $101M | $63M | $27M | $53M | $63M | $14M | $14M | $20M | |
| Operating Income | $-94M | $-103M | $-96M | $-88M | $-97M | $-55M | $-21M | $-43M | $-52M | $-11M | $-3M | $-10M | |
| Interest Expense | · | · | $35.0K | $8.0K | $5.0K | $9.4K | $2.2K | $297.1K | $162.1K | $38.5K | $54.6K | $210.4K | |
| Interest Income | $8M | $8M | $7M | $3M | $203.0K | $322.5K | $843.4K | $226.6K | $47.6K | $1.0K | · | · | |
| Other Non-op | $-190.0K | $48.0K | $166.0K | $-32.0K | $-374.0K | $24.1K | $15.1K | $277.9K | $5.7K | $42.3K | $8.1K | $-762 | |
| Pretax Income | $-89M | $-95M | $-88M | $-85M | $-97M | $-54M | $-21M | $-45M | $-52M | $-11M | $-3M | $-10M | |
| Income Tax | $-681.0K | · | · | $-197.0K | · | $-5M | $-58.5K | $-6M | $-6M | $0 | $61.7K | $61.7K | |
| Net Income | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| EPS (Basic) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.97 | $-0.05 | $-0.17 | |
| EPS (Diluted) | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 | $-1.91 | · | · | · | $2.95 | $-0.05 | $-0.17 | |
| Shares (Basic) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,306,962 | 63,986,013 | 57,535,325 | |
| Shares (Diluted) | 88,104,132 | 71,003,399 | 53,246,937 | 46,926,349 | 41,283,498 | 25,637,023 | · | · | · | 65,657,802 | 63,986,013 | 57,535,325 | |
| EBITDA | $-94M | $-103M | $-96M | $-88M | $-96M | $-55M | $-21M | $-43M | · | $-11M | $-3M | $-10M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $44M | $37M | $135M | $111M | $190M | $116M | $9M | $34M | $9M | $3M | $16M | $19M | |
| Short-term Investments | $230M | $95M | $63M | $74M | · | $100M | $28M | · | · | $67M | $0 | · | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $400.0K | |
| Prepaid Expense | $3M | $2M | $7M | $5M | $8M | $2M | $470.2K | $548.1K | $994.3K | $420.4K | $181.7K | $199.2K | |
| Current Assets | $278M | $137M | $210M | $193M | $204M | $230M | $39M | $39M | $23M | $4M | $17M | $19M | |
| PP&E (Net) | $312.0K | $413.0K | $651.0K | $1M | $1M | $1M | $1M | $1M | $603.1K | $177.9K | $233.7K | $325.8K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $2M | $3M | |
| Accum. Depreciation | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $951.8K | $905.3K | $2M | $2M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | · | $19M | $22M | $2M | |
| Intangibles | · | $0 | $0 | $12M | $12M | $13M | $13M | $14M | $39M | $15M | · | · | |
| Other Non-current Assets | $1M | $2M | $363.0K | $615.0K | $872.0K | $977.2K | $128.5K | $183.7K | $238.9K | $22.2K | $53.4K | $53.4K | |
| Total Assets | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Accounts Payable | $3M | $211.0K | $2M | $5M | $2M | $612.3K | $18.2K | $372.9K | $129.1K | $2M | $521.1K | $391.4K | |
| Accrued Liabilities | · | · | · | · | · | $11M | $4M | $4M | $4M | $3M | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | $71.6K | $49.7K | $458.6K | · | · | |
| Current Liabilities | $15M | $10M | $12M | $17M | $18M | $12M | $4M | $5M | $4M | $5M | $2M | $3M | |
| Capital Leases | $1M | $1M | $175.0K | $672.0K | $1M | $1M | $1M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $58.5K | $6M | $442.6K | $380.8K | $319.0K | |
| Other Non-current Liabilities | $6M | $5M | $40.0K | $60.0K | $80.0K | $110.3K | $130.2K | $140.1K | $160.0K | $442.6K | $433.4K | $493.1K | |
| Total Liabilities | $55M | $16M | $17M | $22M | $20M | $19M | $9M | $6M | $14M | $6M | $3M | $4M | |
| Long-term Debt | $34M | · | · | · | · | · | · | $500.0K | $500.0K | $526.0K | · | · | |
| Total Debt | $34M | · | · | $5M | $1M | $2M | $2M | $71.6K | · | · | $0 | $746.1K | |
| Common Stock | $11.0K | $7.0K | $7.0K | $5.0K | $4.0K | $3.7K | $1.5K | $876 | $61 | $692 | $6.4K | $6.4K | |
| Paid-in Capital | $879M | $690M | $665M | $568M | $497M | $417M | $188M | $170M | $122M | $71M | $240M | $239M | |
| Retained Earnings | $-649M | $-561M | $-466M | $-378M | $-293M | $-186M | $-137M | $-117M | $-78M | $-31M | $-224M | $-220M | |
| AOCI | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-8M | $0 | $-229.5K | |
| Stockholders' Equity | $225M | $124M | $194M | $185M | $199M | $226M | $46M | $48M | $39M | $32M | $43M | $18M | |
| Liabilities + Equity | $280M | $139M | $211M | $207M | $219M | $245M | $54M | $55M | $63M | $38M | $20M | $22M | |
| Shares Outstanding | 110,882,735 | 72,352,701 | 70,677,400 | 49,199,845 | 40,993,768 | 37,142,946 | 15,312,167 | 9,078,238 | 608,499 | 6,917,204 | 64,382,086 | 63,603,303 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $-205.0K | $551.0K | $428.9K | $387.3K | · | · | · | · | · | |
| Stock-based Comp | $16M | $14M | $11M | $8M | $6M | $3M | $1M | $773.2K | $1M | $965.4K | $613.0K | $2M | |
| Deferred Tax | $-681.0K | · | · | · | · | · | $-58.5K | $-6M | $-3M | $61.8K | $61.7K | $61.7K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $0 | $3M | $0 | |
| Other Non-cash | · | · | · | $14M | $13M | $12M | · | · | · | · | · | · | |
| Operating Cash Flow | $-68M | $-80M | $-76M | $-63M | $-78M | $-34M | $-10M | $-9M | $-20M | $-6M | $-3M | $-8M | |
| CapEx | $11.0K | · | $47.0K | $126.0K | $12M | $204.0K | $1.2K | $975.4K | $112.4K | $125.0K | $86.5K | $92.3K | |
| Investing Cash Flow | $-132M | $-28M | $14M | $-73M | $88M | $-72M | $-28M | $-1M | $14M | · | · | · | |
| Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $35M | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Net Stock Activity | $174M | $10M | $87M | $56M | $65M | $48M | · | $4M | · | $4M | $973.1K | $18M | |
| Financing Cash Flow | $207M | $10M | $86M | $57M | $65M | $213M | $13M | $32M | $16M | · | · | · | |
| Net Change in Cash | $7M | $-98M | $24M | $-79M | $74M | $107M | $-25M | $22M | $9M | $138M | $-3M | $8M | |
| Free Cash Flow | $-68M | · | $-76M | $-63M | $-90M | $-35M | $-10M | $-10M | · | $201M | $-3M | $-9M | |
| Levered FCF | · | · | · | $-63M | · | $-35M | $-10M | $-11M | · | · | $-3M | $-9M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% | -669.5% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| Net Margin | -214861.0% | -475295.0% | -20762.2% | 124577.9% | -2201.4% | -599.2% | -353.7% | -379.2% | · | 115286.4% | · | · | |
| Pretax Margin | -216522.0% | -475295.0% | -20762.2% | 124867.7% | -2201.4% | -665.4% | -354.7% | -438.7% | · | 121929.0% | · | · | |
| EBITDA Margin | -230461.0% | -515860.0% | -22518.5% | 129330.9% | -2184.9% | -665.9% | -370.0% | -414.6% | · | -6699.0% | · | · | |
| ROA | -42.0% | -54.3% | -42.4% | -39.8% | -41.9% | -32.8% | -37.7% | -66.5% | · | 158.5% | -16.4% | -50.9% | |
| ROE | -45.6% | -74.0% | -51.3% | -43.4% | -47.5% | -23.1% | -43.2% | -89.0% | · | 619.4% | -19.7% | -77.8% | |
| ROIC | -36.2% | · | · | -46.1% | · | -21.7% | -45.2% | -76.5% | · | -54.7% | -20.8% | -53.9% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 | 19.2 | 10.0 | 8.7 | · | 1.1 | 7.9 | 7.5 | |
| Quick Ratio | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 | 18.0 | 9.5 | 7.4 | · | 1.1 | 7.1 | 7.4 | |
| Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | 0.0 | |
| LT Debt / Equity | 0.2 | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -2740.8 | -10967.5 | -17134.7 | -5816.7 | -9565.5 | -144.2 | · | · | -62.3 | -48.4 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | -0.0 | 0.0 | 0.1 | 0.1 | 0.2 | · | 0.0 | · | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 105.0% | -95.3% | · | · | -46.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -83.5% | -62.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -65.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41.0K | $20.0K | $426.0K | $-68.0K | $4M | $8M | $6M | $10M | $11M | $3M | · | · | |
| Net Income TTM | $-88M | $-95M | $-88M | $-85M | $-97M | $-49M | $-21M | $-39M | $-46M | $-11M | $-3M | $-10M | |
| Market Cap | $400M | $522M | $795M | $809M | $376M | $419M | $29M | $19M | · | · | · | · | |
| Enterprise Value | $161M | · | · | $629M | $187M | $205M | $-6M | $-15M | · | · | · | · | |
| P/E | -3.6 | -5.4 | -6.8 | -9.1 | -3.9 | -5.9 | 0.6 | 0.7 | 20.4 | · | · | · | |
| P/S | 9763.1 | 26083.1 | 1866.5 | -11902.0 | 85.1 | 51.2 | 5.0 | 1.8 | · | · | · | · | |
| P/B | 1.8 | 4.2 | 4.1 | 4.4 | 1.9 | 1.9 | 0.6 | 0.4 | · | · | · | · | |
| P / Tangible Book | 1.8 | 4.2 | 4.1 | 4.7 | 2.0 | 2.0 | · | · | · | · | · | · | |
| P / Cash Flow | -5.9 | -6.5 | -10.5 | -12.9 | -4.8 | -12.2 | -3.0 | -2.0 | · | · | · | · | |
| P / FCF | -5.9 | · | -10.5 | -12.9 | -4.2 | -12.1 | -3.0 | -1.8 | · | · | · | · | |
| EV / EBITDA | -1.7 | · | · | -7.2 | -1.9 | -3.8 | 0.3 | 0.3 | · | · | · | · | |
| EV / FCF | -2.4 | · | · | -10.0 | -2.1 | -5.9 | 0.7 | 1.4 | · | · | · | · | |
| EV / Revenue | 3929.7 | · | · | -9250.6 | 42.3 | 25.0 | -1.1 | -1.4 | · | · | · | · | |
| Earnings Yield | -27.7% | -18.6% | -14.8% | -11.0% | -25.7% | -16.9% | 154.5% | 141.8% | 4.9% | · | · | · |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $26.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $37.0K | $362.0K | $6.0K | $21.0K | $-110.0K | $2.0K | |
| R&D Expense | $19M | $16M | $18M | $15M | $17M | $16M | $20M | $20M | $21M | $21M | $17M | $18M | $13M | $17M | $19M | $20M | |
| SG&A Expense | $8M | $8M | $11M | $6M | $6M | $6M | $5M | $5M | $6M | $5M | $4M | $5M | $5M | $5M | $4M | $4M | |
| Operating Expenses | $26M | $24M | $29M | $21M | $23M | $22M | $25M | $25M | $27M | $27M | $34M | $23M | $18M | $22M | $23M | $25M | |
| Operating Income | $-26M | $-24M | $-29M | $-21M | $-23M | $-22M | $-25M | $-25M | $-27M | $-27M | $-34M | $-23M | $-18M | $-22M | $-23M | $-25M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1.0K | · | $29.0K | $2.0K | $2.0K | $-183.0K | $64.0K | |
| Interest Income | $5M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-op | $-25.0K | $-152.0K | $-27.0K | $-86.0K | $-92.0K | $15.0K | $118.0K | $18.0K | $-76.0K | $-12.0K | $20.0K | $14.0K | $113.0K | $19.0K | $-217.0K | $50.0K | |
| Pretax Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | · | · | $-22M | $-24M | |
| Income Tax | · | · | $0 | $0 | $0 | $-681.0K | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $-197.0K | |
| Net Income | $-23M | $-23M | $-27M | $-19M | $-22M | $-20M | $-23M | $-23M | $-25M | $-24M | $-32M | $-21M | $-16M | $-20M | $-22M | $-24M | |
| EPS (Basic) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| EPS (Diluted) | $-0.12 | $-0.18 | $-0.26 | $-0.21 | $-0.27 | $-0.26 | $-0.33 | $-0.32 | $-0.35 | $-0.34 | $-0.55 | $-0.39 | $-0.32 | $-0.40 | $-0.47 | $-0.48 | |
| Shares (Basic) | 185,443,736 | 124,461,818 | -158,339,190 | 89,418,028 | 81,477,548 | 75,547,746 | -141,807,472 | 71,084,787 | 70,924,371 | 70,801,713 | -101,203,660 | 53,633,354 | 50,691,558 | 50,125,685 | -93,832,266 | 49,286,535 | |
| Shares (Diluted) | 185,443,736 | 124,461,818 | -158,339,190 | 89,418,028 | 81,477,548 | 75,547,746 | -141,807,472 | 71,084,787 | 70,924,371 | 70,801,713 | -101,203,660 | 53,633,354 | 50,691,558 | 50,125,685 | -93,832,266 | 49,286,535 | |
| EBITDA | $-26M | $-24M | · | $-21M | $-23M | $-22M | · | $-25M | $-27M | $-27M | · | $-23M | $-18M | $-22M | · | $-25M |
Bilanz 24
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $98M | $44M | $61M | $183M | $49M | $37M | $31M | $57M | $79M | $135M | $87M | $102M | $105M | $111M | $127M | |
| Short-term Investments | $263M | $234M | $230M | $150M | · | $101M | $95M | $108M | $108M | $103M | $63M | $54M | $58M | $61M | $74M | $74M | |
| Prepaid Expense | $5M | $1M | $3M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $7M | $8M | $6M | $4M | $5M | $5M | |
| Current Assets | $335M | $335M | $278M | $217M | $188M | $155M | $137M | $146M | $171M | $188M | $210M | $153M | $170M | $173M | $193M | $211M | |
| PP&E (Net) | $60.0K | $208.0K | $312.0K | $337.0K | $364.0K | $384.0K | $413.0K | $446.0K | $483.0K | $544.0K | $651.0K | $765.0K | $882.0K | $1M | $1M | $1M | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | · | · | $3M | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $1M | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | · | $12M | |
| Other Non-current Assets | $90.0K | $746.0K | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $299.0K | $363.0K | $425.0K | $483.0K | $546.0K | $615.0K | $682.0K | |
| Total Assets | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Accounts Payable | $1M | $2M | $3M | $5M | $851.0K | $1M | $211.0K | $1M | $3M | $4M | $2M | $3M | $4M | $5M | $5M | $1M | |
| Current Liabilities | $13M | $11M | $15M | $13M | $9M | $10M | $10M | $9M | $15M | $11M | $12M | $12M | $11M | $15M | $17M | $16M | |
| Capital Leases | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $44.0K | $175.0K | $303.0K | $429.0K | $552.0K | $672.0K | $788.0K | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $5M | $16.0K | $5M | $26.0K | $31.0K | $37.0K | $40.0K | $46.0K | $52.0K | $56.0K | $60.0K | $66.0K | |
| Total Liabilities | $53M | $52M | $55M | $33M | $29M | $15M | $16M | $14M | $21M | $15M | $17M | $16M | $16M | $19M | $22M | $20M | |
| Long-term Debt | $35M | $35M | $34M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $35M | $35M | · | $14M | $14M | · | · | · | · | · | · | $4M | $4M | $4M | · | $5M | |
| Common Stock | $19.0K | $13.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $1.18B | $961M | $879M | $813M | $770M | $728M | $690M | $676M | $673M | $669M | $665M | $590M | $587M | $571M | $568M | $567M | |
| Retained Earnings | $-695M | $-672M | $-649M | $-622M | $-603M | $-581M | $-561M | $-538M | $-515M | $-491M | $-466M | $-435M | $-414M | $-398M | $-378M | $-356M | |
| AOCI | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | |
| Stockholders' Equity | $474M | $284M | $225M | $186M | $161M | $142M | $124M | $133M | $153M | $173M | $194M | $150M | $168M | $168M | $185M | $205M | |
| Liabilities + Equity | $527M | $336M | $280M | $218M | $190M | $157M | $139M | $148M | $173M | $188M | $211M | $167M | $183M | $187M | $207M | $225M | |
| Shares Outstanding | 194,474,154 | 130,221,154 | 110,882,735 | 95,598,665 | 85,076,300 | 77,825,450 | 72,352,701 | 71,124,407 | 71,046,267 | 70,899,134 | 70,677,400 | 52,858,920 | 52,657,661 | 49,286,710 | 49,199,845 | 49,161,637 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $-552.0K | $-505.0K | $-356.0K | · | $-141.0K | |
| Stock-based Comp | $3M | $3M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $4M | $2M | $3M | $3M | $3M | $2M | $2M | |
| Deferred Tax | · | · | $0 | $0 | $0 | $-681.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-24M | $-21M | $-19M | $-12M | $-19M | $-17M | $-18M | $-27M | $-18M | $-16M | $-17M | $-20M | $-19M | $-19M | $-17M | $-15M | |
| CapEx | $32.0K | $21.0K | $1.0K | $0 | · | · | · | · | · | · | $0 | $0 | $-4.0K | $51.0K | $38.0K | $60.0K | |
| Investing Cash Flow | $-221M | $-4M | $-79M | $-149M | $101M | $-5M | $14M | $1M | $-4M | $-40M | $-8M | $4M | $4M | $13M | $981.0K | $-25M | |
| Debt Issued | · | · | $20M | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $-89.0K | $9M | $62M | $40M | $38M | $35M | · | · | · | · | $73M | $510.0K | · | · | $0 | $32M | |
| Net Stock Activity | · | $9M | · | · | · | $35M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $211M | $78M | $81M | $39M | $52M | $34M | $10M | $266.0K | $-46.0K | $-261.0K | $73M | $588.0K | $13M | $-302.0K | $-43.0K | $32M | |
| Net Change in Cash | $-35M | $54M | $-17M | $-122M | $134M | $12M | $5M | $-26M | $-22M | $-56M | $48M | $-15M | $-2M | $-6M | $-16M | $-8M | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | · | · | · | · | $-19M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -103614.3% | · | -1237600.0% | |
| Net Margin | · | · | · | -380280.0% | -442920.0% | -391500.0% | · | -456900.0% | -492800.0% | -487880.0% | · | -5710.2% | -267683.3% | -95590.5% | · | -1175800.0% | |
| Pretax Margin | · | · | · | -380280.0% | -442920.0% | -405120.0% | · | · | · | · | · | -5710.2% | · | · | · | -1185650.0% | |
| EBITDA Margin | · | · | · | -417180.0% | -458440.0% | -436300.0% | · | -495340.0% | -534900.0% | -535880.0% | · | -6226.5% | -300116.7% | -105309.5% | · | -1237600.0% | |
| ROA | -6.4% | -9.2% | · | -10.4% | -12.2% | -11.3% | · | -14.5% | -13.8% | -13.0% | · | -10.5% | -8.2% | -10.2% | · | -10.2% | |
| ROE | -7.2% | -10.6% | · | -11.9% | -14.1% | -12.4% | · | -16.1% | -15.4% | -14.3% | · | -11.6% | -8.9% | -11.4% | · | -11.3% | |
| ROIC | · | · | · | · | · | -14.8% | · | · | · | · | · | · | · | · | · | -11.7% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 26.8 | 29.6 | · | 17.2 | 20.4 | 15.8 | · | 16.9 | 11.3 | 16.5 | · | 12.9 | 14.8 | 11.6 | · | 13.4 | |
| Quick Ratio | 26.1 | 29.3 | · | 16.7 | 19.9 | 15.3 | · | 16.1 | 10.9 | 16.1 | · | 11.9 | 14.0 | 11.1 | · | 12.8 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -26794.0 | · | -777.2 | -9003.5 | -10879.5 | · | -386.8 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20.0K | $20.0K | · | $20.0K | $20.0K | $20.0K | · | $377.0K | $378.0K | $394.0K | · | $391.0K | $37.0K | $63.0K | · | $200.0K | |
| Net Income TTM | $-87M | $-83M | · | $-84M | $-89M | $-91M | · | $-93M | $-86M | $-81M | · | $-80M | $-80M | $-83M | · | $-97M | |
| Market Cap | $591M | $401M | · | $360M | $329M | $389M | · | $437M | $472M | $722M | · | $137M | $186M | $208M | · | $628M | |
| Enterprise Value | $300M | $104M | · | $164M | $160M | · | · | · | · | · | · | $959.2K | $30M | $47M | · | $430M | |
| P/E | -3.9 | -3.3 | · | -3.6 | -3.2 | -3.9 | · | -4.4 | -4.8 | -7.0 | · | -1.6 | -2.2 | -2.4 | · | -5.9 | |
| P/S | 29560.1 | 20054.1 | · | 18020.3 | 16462.3 | 19456.4 | · | 1158.4 | 1249.9 | 1831.9 | · | 351.5 | 5023.8 | 3301.4 | · | 3139.0 | |
| P/B | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.1 | |
| P / Tangible Book | 1.2 | 1.4 | · | 1.9 | 2.0 | 2.7 | · | 3.3 | 3.1 | 4.2 | · | 0.9 | 1.1 | 1.2 | · | 3.3 | |
| P / Cash Flow | · | -19.2 | · | · | · | -23.1 | · | · | · | -44.1 | · | · | · | -10.7 | · | · | |
| P / FCF | · | -19.1 | · | · | · | · | · | · | · | · | · | · | · | -10.7 | · | · | |
| EV / EBITDA | -11.4 | -4.3 | · | -7.9 | -7.0 | · | · | · | · | · | · | -0.0 | -1.7 | -2.1 | · | -17.4 | |
| EV / FCF | · | -5.0 | · | · | · | · | · | · | · | · | · | · | · | -2.4 | · | · | |
| EV / Revenue | 14983.1 | 5202.3 | · | 8203.8 | 8023.6 | · | · | · | · | · | · | 2.5 | 813.3 | 740.6 | · | 2152.4 | |
| Earnings Yield | -25.7% | -29.9% | · | -28.1% | -31.0% | -25.4% | · | -22.8% | -21.1% | -14.2% | · | -61.2% | -45.9% | -41.2% | · | -16.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $41.0K | $20.0K | $426.0K | $-68.0K | $4M |
| Betriebsgewinnmarge % | -230461.0% | -515860.0% | -22518.5% | 129029.4% | -2197.4% |
| Nettoergebnis | $-88M | $-95M | $-88M | $-85M | $-97M |
| Verwässerte EPS | $-1.00 | $-1.34 | $-1.66 | $-1.81 | $-2.35 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | — | — | 0.0 | 0.0 |
| Liquiditätsgrad | 18.5 | 13.1 | 17.3 | 11.3 | 11.2 |
| Quick Ratio | 18.2 | 12.6 | 16.3 | 10.8 | 10.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-68M | — | $-76M | $-63M | $-90M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 238 Einreicher · $355.5M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 65 (+39 vs. Vorquartal) | 16 (-17 vs. Vorquartal) | 78 (-4 vs. Vorquartal) | 38 (-1 vs. Vorquartal) | +79.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Deep Track Capital, LP | $58.520.000 | 19.250.000 | 16,46% | Aktien |
| STATE STREET CORP | $36.779.562 | 12.098.540 | 10,35% | Aktien |
| TCG Crossover Management, LLC | $30.400.000 | 10.000.000 | 8,55% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $24.860.366 | 8.177.752 | 6,99% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22.284.006 | 7.330.265 | 6,27% | Aktien |
| VIKING GLOBAL INVESTORS LP | $20.368.000 | 6.700.000 | 5,73% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $19.760.000 | 6.500.000 | 5,56% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $13.042.903 | 4.289.189 | 3,67% | Aktien |
| Woodline Partners LP | $10.336.948 | 3.400.312 | 2,91% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $10.059.731 | 3.309.122 | 2,83% | Aktien |
| Trails Edge Capital Partners, LP | $8.086.400 | 2.660.000 | 2,27% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.238.672 | 2.381.142 | 2,04% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.713.595 | 1.879.472 | 1,61% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.469.872 | 1.799.300 | 1,54% | Kaufoption |
| GREAT POINT PARTNERS LLC | $5.293.345 | 1.741.232 | 1,49% | Aktien |
| Weiss Asset Management LP | $4.653.641 | 1.530.803 | 1,31% | Aktien |
| Nantahala Capital Management, LLC | $4.560.000 | 1.500.000 | 1,28% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.930.723 | 1.293.001 | 1,11% | Aktien |
| Cormorant Asset Management, LP | $3.800.000 | 1.250.000 | 1,07% | Aktien |
| TWO SIGMA ADVISERS, LP | $2.865.979 | 793.900 | 0,81% | Aktien |
| VANGUARD GROUP INC | $2.531.996 | 701.384 | 0,71% | Aktien |
| MARSHALL WACE, LLP | $2.424.799 | 797.631 | 0,68% | Aktien |
| Ghisallo Capital Management LLC | $2.280.000 | 750.000 | 0,64% | Aktien |
| FMR LLC | $2.276.297 | 748.782 | 0,64% | Aktien |
| BlackRock, Inc. | $2.190.606 | 720.594 | 0,62% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $2.024.707 | 666.022 | 0,57% | Aktien |
| CITADEL ADVISORS LLC | $1.918.240 | 631.000 | 0,54% | Kaufoption |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.898.477 | 624.499 | 0,53% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.789.581 | 588.678 | 0,50% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.711.815 | 563.097 | 0,48% | Aktien |
| Point72 Asset Management, L.P. | $1.480.127 | 486.884 | 0,42% | Aktien |
| Rock Springs Capital Management LP | $1.433.254 | 471.465 | 0,40% | Aktien |
| Beirne Wealth Consulting Services, LLC | $1.282.449 | 421.858 | 0,36% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $1.128.375 | 371.176 | 0,32% | Aktien |
| BARCLAYS PLC | $1.021.313 | 335.958 | 0,29% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $990.128 | 325.700 | 0,28% | Verkaufsoption |
| RHUMBLINE ADVISERS | $941.193 | 309.606 | 0,26% | Aktien |
| LMR Partners LLP | $912.000 | 300.000 | 0,26% | Aktien |
| CITIGROUP INC | $857.496 | 282.071 | 0,24% | Aktien |
| Steward Partners Investment Advisory, LLC | $810.680 | 266.671 | 0,23% | Aktien |
| MANGROVE PARTNERS IM, LLC | $727.411 | 239.280 | 0,20% | Aktien |
| Baird Financial Group, Inc. | $722.067 | 237.522 | 0,20% | Aktien |
| BROWN WEALTH MANAGEMENT, LLC | $717.853 | 236.136 | 0,20% | Aktien |
| JANE STREET GROUP, LLC | $691.296 | 227.400 | 0,19% | Kaufoption |
| Rafferty Asset Management, LLC | $684.182 | 225.060 | 0,19% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $652.300 | 214.574 | 0,18% | Aktien |
| WOLVERINE TRADING, LLC | $637.478 | 168.200 | 0,18% | Kaufoption |
| Squarepoint Ops LLC | $615.235 | 202.380 | 0,17% | Aktien |
| ALPS ADVISORS INC | $600.017 | 197.374 | 0,17% | Aktien |
| STIFEL FINANCIAL CORP | $584.799 | 192.368 | 0,16% | Aktien |
| Jump Financial, LLC | $577.600 | 190.000 | 0,16% | Aktien |
| Man Group plc | $528.571 | 173.872 | 0,15% | Aktien |
| WELLS FARGO & COMPANY/MN | $506.063 | 166.468 | 0,14% | Aktien |
| Knoll Capital Management, LLC | $486.400 | 160.000 | 0,14% | Aktien |
| Birchview Capital, LP | $464.150 | 152.681 | 0,13% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $433.818 | 140.850 | 0,12% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $407.053 | 133.899 | 0,11% | Aktien |
| Brevan Howard Capital Management LP | $397.574 | 130.781 | 0,11% | Aktien |
| XTX Topco Ltd | $389.388 | 128.088 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $389.120 | 128.000 | 0,11% | Verkaufsoption |
| Virtus Investment Advisers, LLC | $381.104 | 125.363 | 0,11% | Aktien |
| WEALTH EFFECTS LLC | $372.856 | 122.650 | 0,10% | Aktien |
| LPL Financial LLC | $370.734 | 121.952 | 0,10% | Aktien |
| MetLife Investment Management, LLC | $355.242 | 116.856 | 0,10% | Aktien |
| PROFUND ADVISORS LLC | $345.338 | 113.598 | 0,10% | Aktien |
| D. E. Shaw & Co., Inc. | $340.285 | 111.936 | 0,10% | Aktien |
| Jefferies Financial Group Inc. | $334.400 | 110.000 | 0,09% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $314.640 | 103.500 | 0,09% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $314.257 | 103.374 | 0,09% | Aktien |
| Summit Financial Wealth Advisors, LLC | $313.996 | 103.288 | 0,09% | Aktien |
| ADAR1 Capital Management, LLC | $312.582 | 102.823 | 0,09% | Aktien |
| Mariner, LLC | $307.407 | 101.123 | 0,09% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $304.000 | 100.000 | 0,09% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $278.276 | 91.538 | 0,08% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $265.392 | 87.300 | 0,07% | Aktien |
| Grantham, Mayo, Van Otterloo & Co. LLC | $254.864 | 83.837 | 0,07% | Aktien |
| Invesco Ltd. | $241.625 | 79.482 | 0,07% | Aktien |
| Vanguard Global Advisers, LLC | $228.137 | 75.045 | 0,06% | Aktien |
| KINGSWOOD WEALTH ADVISORS, LLC | $226.480 | 74.500 | 0,06% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $217.664 | 71.600 | 0,06% | Aktien |
| Bank of New York Mellon Corp | $206.136 | 67.808 | 0,06% | Aktien |
| IEQ CAPITAL, LLC | $203.540 | 66.954 | 0,06% | Aktien |
| PVG ASSET MANAGEMENT CORP | $201.005 | 66.120 | 0,06% | Aktien |
| HSBC HOLDINGS PLC | $199.504 | 64.460 | 0,06% | Aktien |
| Leonteq Securities AG | $194.560 | 64.000 | 0,05% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $178.220 | 58.625 | 0,05% | Aktien |
| AXQ CAPITAL, LP | $172.702 | 56.810 | 0,05% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $172.499 | 56.743 | 0,05% | Aktien |
| WOLVERINE TRADING, LLC | $163.728 | 43.200 | 0,05% | Verkaufsoption |
| MERCER GLOBAL ADVISORS INC /ADV | $161.470 | 53.115 | 0,05% | Aktien |
| Corient Private Wealth LP | $161.219 | 53.032 | 0,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $160.351 | 52.747 | 0,05% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $158.189 | 52.036 | 0,04% | Aktien |
| Cetera Investment Advisers | $157.779 | 51.901 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $150.176 | 49.400 | 0,04% | Verkaufsoption |
| Caption Management, LLC | $141.716 | 46.617 | 0,04% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $139.569 | 45.911 | 0,04% | Aktien |
| Quantbot Technologies LP | $138.721 | 45.632 | 0,04% | Aktien |
| Graham Capital Management, L.P. | $136.618 | 44.940 | 0,04% | Aktien |
| AMERIPRISE FINANCIAL INC | $135.639 | 44.618 | 0,04% | Aktien |
Unternehmensinsider 48 Insider · 25 Führungskräfte · 20 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Vipin K Garg | President and CEO | 2. Februar 2025 M | 355.082 | 0 | 0 | $0 |
| William Enright | President and CEO | 25. Mai 2018 P | 365.839 | 0 | 0 | $0 |
| David P Wright | President and CEO | 11. Dezember 2009 P | 399.500 | 0 | 0 | $0 |
| Gregory L Weaver | Chief Financial Officer | 31. Juli 2026 A | 39.831 | 2 | 0 | $49.200 |
| Andrew Shutterly | Acting Chief Financial Officer | 31. Juli 2024 A | 11.372 | 0 | 0 | $0 |
| Richard I Eisenstadt | Chief Financial Officer | 30. Januar 2024 M | 45.012 | 0 | 0 | $0 |
| William Michael Brown | Chief Financial Officer | 31. Juli 2021 A | 17.721 | 0 | 0 | $0 |
| Elizabeth Czerepak | CFO and EVP Corp. Development | 22. September 2017 A | — | 0 | 0 | $0 |
| MACNEILL PHILIP | VP, CFO, Treasurer, Secretary | 21. Dezember 2016 M | 126.346 | 0 | 0 | $0 |
| Linda L Chang | SVP, CFO & Secretary | 7. Januar 2015 M | 30.000 | 0 | 0 | $0 |
| Charles A. Reinhart III | SVP, Chief Financial Officer | 8. Dezember 2010 A | — | 0 | 0 | $0 |
| Kevin Price | President - PharmAthene UK,Ltd | 21. Januar 2009 A | 2.500 | 0 | 0 | $0 |
| Jeffrey Michael Jones | COO | 11. März 2015 A | 27.544 | 0 | 0 | $0 |
| Scot M Roberts | Chief Scientific Officer | 31. Juli 2026 A | 113.699 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 1. Oktober 2025 A | — | 0 | 0 | $0 |
| Linda M Richardson | Chief Commercial Officer | 16. September 2025 A | — | 0 | 0 | $0 |
| Raymond M Jordt | Chief Business Officer | 31. Juli 2025 A | 36.270 | 0 | 0 | $0 |
| Matthew Scott Harris | Chief Medical Officer | 31. Juli 2025 A | 16.087 | 0 | 0 | $0 |
| Sybil Tasker | Chief Medical Officer | 17. Juni 2019 A | — | 0 | 0 | $0 |
| Wayne Morges | SVP, Reg. Affairs & Quality | 8. Dezember 2014 A | 35.532 | 0 | 0 | $0 |
| Francesca M Cook | SVP, Policy & Gov't Affairs | 8. Dezember 2014 A | 37.631 | 0 | 0 | $0 |
| Thomas Richard Fuerst | EVP, Chief Scientific Officer | 1. Dezember 2011 A | 15.000 | 0 | 0 | $0 |
| Valerie D Riddle | SVP, Medical Director | 31. Mai 2011 M | 44.436 | 0 | 0 | $0 |
| Joan Fusco | SVP, Operations | 6. Mai 2010 A | 36.730 | 0 | 0 | $0 |
| Christopher C Camut | VP, Gov't Contracts | 21. Januar 2010 F | 46.777 | 0 | 0 | $0 |
| Mitchel Sayare | Direktor | 1. Mai 2026 A | 26.363 | 0 | 0 | $0 |
| Teri L Lawver | Direktor | 25. September 2025 A | — | 0 | 0 | $0 |
| Wayne Pisano | Direktor | 25. September 2025 A | 8.498 | 0 | 0 | $0 |
| Klaus Schafer | Direktor | 25. September 2025 A | 9.179 | 0 | 0 | $0 |
| Philip Hodges | Direktor | 25. September 2025 A | 8.731 | 0 | 0 | $0 |
| Catherine A. Sohn | Direktor | 25. September 2025 A | 1.000 | 0 | 0 | $0 |
| Diane Jorkasky | Direktor | 25. September 2025 A | 0 | 0 | 0 | $0 |
| John Gill | Direktor | 25. September 2025 A | 0 | 0 | 0 | $0 |
| David Drutz | Direktor | 19. August 2024 M | 55.524 | 0 | 0 | $0 |
| SCHAFFER DERACE L | Direktor | 29. Dezember 2017 P | 589.453 | 0 | 0 | $0 |
| Jeffrey W. Runge | Direktor | 20. Januar 2017 M | 197.700 | 0 | 0 | $0 |
| Steven St Peter | Direktor | 4. Januar 2017 M | 205.004 | 0 | 0 | $0 |
| Eric I Richman | Direktor | 22. November 2016 M | 898.055 | 0 | 0 | $0 |
| Joel Mccleary | Direktor | 31. Dezember 2014 A | 120.167 | 0 | 0 | $0 |
| Brian A Markison | Direktor | 31. Dezember 2014 A | — | 0 | 0 | $0 |
| John Pappajohn | Direktor | 23. Juni 2011 A | 394.044 | 0 | 0 | $0 |
| CAVANAUGH JAMES H | Direktor | 23. Juni 2010 A | — | 0 | 0 | $0 |
| VELOCITY PHARMACEUTICAL HOLDINGS LLC | 10%-Eigentümer | 15. Mai 2020 S | 1.687.250 | 0 | 0 | $0 |
| Truffle Capital S.A.S. | 10%-Eigentümer | 13. Februar 2018 J | 76.700 | 0 | 0 | $0 |
| ANSBERT GADICKE | 10%-Eigentümer | 3. August 2007 A | — | 0 | 0 | $0 |
| Jerome Benedict Durso | — | 13. August 2026 P | 62.500 | 1 | 0 | $44.250 |
| Jordan P Karp | — | 3. Dezember 2012 A | 21.929 | 0 | 0 | $0 |
| Matthew P Kinley | — | 3. August 2007 P | 541.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 18 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management II, LLC, VHCP Management III, LLC, Shah, Nimish, Koh, Bong | 25. Juni 2020 | — | Erste Einreichung | Passive Anlage | SEC |
| Philip Hodges, Redmont Venture Partners, Inc., Redmont VAXN Capital Holdings, LLC, Paradigm Venture Partners, L.P. ×3 Einreichungen | 19. Oktober 2017 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 30. März 2016 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 12. Februar 2016 | — | Erste Einreichung | — | SEC |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., PRESCOTT GROUP AGGRESSIVE SMALL CAP, L.P., PRESCOTT GROUP AGGRESSIVE SMALL CAP II, L.P., PHIL FROHLICH ×6 Einreichungen | 2. Dezember 2013 | — | Erste Einreichung | — | SEC |
| Theraclone Sciences, Inc. | 12. August 2013 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 27. Dezember 2010 | — | Erste Einreichung | Passive Anlage | SEC |
| Kelisia Holdings L imited, Panacea Biotec Limited | 18. September 2009 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 4. August 2009 | — | Erste Einreichung | Passive Anlage | SEC |
| HealthCare Ventures VII, L.P., HealthCare Partners VII, L.P., James H. Cavanaugh, Ph.D., John Littlechild, Harold Werner, Augustine Lawlor, Christopher Mirabelli, Ph.D. ×3 Einreichungen | 3. August 2009 | — | Erste Einreichung | — | SEC |
| Bear Stearns Health Innoventures, L.P., Bear Stearns Health Innoventures Offshore, L.P., BX, L.P., Bear Stearns Health Innoventures Employee Fund, L.P., BSHI Members, L.L.C., Bear Stearns Health Innoventures Management, L.L.C., Bear Stearns Asset Management Inc. ×3 Einreichungen | 29. Mai 2009 | — | Erste Einreichung | Vorstandskampagne | SEC |
| Integrated Core Strategies (US) LLC, Riverview Group LLC, Millennium Management LLC, Israel A. Englander ×2 Einreichungen | 23. April 2009 | — | Erste Einreichung | — | SEC |
| Nexia Biotechnologies Ltd. | 30. Mai 2008 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 17. August 2007 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 14. August 2007 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 32 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 36.663 SH | 8. August 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,36% | 52.374 NS | 30. April 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,25% | 134.076 NS | 31. Mai 2026 | N-PORT |
| IWC · iShares Trust | 0,14% | 673.112 SH | 8. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,12% | 248.923 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,04% | 1.339.073 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,04% | 10.586 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 172.834 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,04% | 1.851.172 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.142.675 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 183.761 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,02% | 4.631 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 5.057.242 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 56.560 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 2.235.429 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 6.144 NS | 31. Mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 569.267 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 414.821 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 4.804 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4.861 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 122 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 358.663 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.514 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 8.167 NS | 30. April 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 763 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 23.287 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 25.408 NS | 30. April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9.653 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 34.439 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.748.771 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 16.865 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 353 NS | 31. Mai 2026 | N-PORT |